Humana Inc. (NYSE:HUM) receives a consensus price target of $403.55 from brokerages

Shares of Humana Inc. (NYSE:HUM – Get Your Free Report ) has received a consensus recommendation of “Hold” from the twenty-one ratings firms that are covering the firm, Marketbeat reports. Twelve equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $403.55.

HUM has been the subject of several research analyst reports. Bank of America boosted their price objective on shares of Humana from $342.00 to $376.00 and gave the stock a “neutral” rating in a research note on Monday, May 20th. Baird RW upgraded shares of Humana to a “hold” rating in a research note on Thursday, May 30th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Humana from $341.00 to $349.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. TD Cowen lifted their price target on shares of Humana from $396.00 to $407.00 and gave the stock a “buy” rating in a research note on Wednesday, July 24th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and set a $360.00 target price on shares of Humana in a research note on Tuesday, July 23rd.

Get the latest stock report on HUM

Humana trading rose 0.1%

NYSE:HUM opened at $350.83 on Thursday. Humana has a 12-month low of $298.61 and a 12-month high of $530.54. The firm has a market cap of $42.28 billion, a price-to-earnings ratio of 21.84, a P/E/G ratio of 2.09 and a beta of 0.51. The company has a quick ratio of 1.67, a current ratio of 1.66, and a debt-to-equity ratio of 0.70. The company’s 50-day moving average is $368.08 and its 200-day moving average is $346.87.

Humana (NYSE:HUM – Get Your Free Report ) last announced its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.89 by $1.07. The business had revenue of $29.54 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. Humana’s quarterly revenue was up 10.4% year over year. In the same quarter last year, the company posted earnings of $8.94 per share. equities analysts anticipate that Humana will post 16.14 EPS for the current year.

Institutional inputs and outputs

Institutional investors have recently made changes to their positions in the business. Pzena Investment Management LLC boosted its holdings in Humana by 538.7% in the 2nd quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock worth $866,250,000 after purchasing an additional 1,955 shares. .375 shares in the last quarter. Norges Bank bought a new stake in Humana in the 4th quarter valued at approximately $676,800,000. Sanders Capital LLC bought a new stake in Humana in the 4th quarter valued at about $489,300,000. Ontario Teachers Pension Plan Board boosted its holdings in Humana by 11,647.2% in the first quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock worth $367,342,000 after buying an additional 1,050,459 shares in the last quarter. Finally, Putnam Investments LLC boosted its holdings in Humana by 550.3% during the 4th quarter. Putnam Investments LLC now owns 875,489 shares of the insurance provider’s stock worth $400,808,000 after buying another 740,858 shares in the last quarter. 92.38% of shares are owned by institutional investors.

About Humana

(Get a free report

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. Has a contract with the Centers for Medicare and Medicaid Services to administer the newly eligible limited income transition program for prescription drugs; and contracts with various states to provide Medicaid benefits, dual eligibles, and long-term care services.

Recommended articles

Get news and reviews for Humana Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Humana and related companies with MarketBeat.com’s FREE daily email newsletter.